Works matching AU Wang, Sue Jane

Results: 84

Unblinded Adaptive Statistical Information Design Based on Clinical Endpoint or Biomarker.

Published in:

Statistics in Biopharmaceutical Research, 2013, v. 5, n. 4, p. 293, doi. 10.1080/19466315.2013.791639

By:

Wang *, Sue-Jane;
Brannath *, Werner;
Brückner, Matthias;
James Hung, H. M.;
Koch, Armin

Publication type:

Article

Statistical Considerations for Noninferiority Trial Designs Without Placebo.

Published in:

Statistics in Biopharmaceutical Research, 2013, v. 5, n. 3, p. 239, doi. 10.1080/19466315.2013.782821

By:

James Hung, H. M.;
Wang, Sue-Jane

Publication type:

Article

MARKET REACTIONS TO THE PASSAGE OF THE FINANCIAL HOLDING COMPANY ACT IN TAIWAN.

Published in:

Pacific Economic Review, 2008, v. 13, n. 4, p. 453, doi. 10.1111/j.1468-0106.2008.00412.x

By:

JANE-SUE WANG;
JING-TWEN CHEN;
PIN-HUANG CHOU

Publication type:

Article

Sample size for gene expression microarray experiments†The views presented in this paper are those of the authors and not necessarily representing those of the US Food and Drug Administration.

Published in:

Bioinformatics, 2005, v. 21, n. 8, p. 1502, doi. 10.1093/bioinformatics/bti162

By:

Chen-An Tsai;
Sue-Jane Wang;
Dung-Tsa Chen;
James J. Chen

Publication type:

Article

Issues with Statistical Risks for Testing Methods in Noninferiority Trial Without a Placebo ARM.

Published in:

Journal of Biopharmaceutical Statistics, 2007, v. 17, n. 2, p. 201, doi. 10.1080/10543400601177343

By:

Hung, H. M.James;
Wang, Sue-Jane;
O'Neill, Robert

Publication type:

Article

Adaptive Statistical Analysis Following Sample Size Modification Based on Interim Review of Effect Size.

Published in:

Journal of Biopharmaceutical Statistics, 2005, v. 15, n. 4, p. 693, doi. 10.1081/BIP-200062855

By:

James Hung, H. M.;
Cui, Lu;
Wang, Sue-Jane;
Lawrence, John

Publication type:

Article

Adaptive Covariate Adjustment in Clinical Trials.

Published in:

Journal of Biopharmaceutical Statistics, 2005, v. 15, n. 4, p. 605, doi. 10.1081/BIP-200062280

By:

Wang, Sue-Jane;
James Hung, H.M.

Publication type:

Article

Multiple Testing of Noninferiority Hypotheses in Active Controlled Trials#.

Published in:

Journal of Biopharmaceutical Statistics, 2004, v. 14, n. 2, p. 327, doi. 10.1081/BIP-120037183

By:

James Hung, H. M.;
Wang, Sue-Jane

Publication type:

Article

Group Sequential Design and Analysis of Clinical Equivalence Assessment for Generic Nonsystematic Drug Products#.

Published in:

Journal of Biopharmaceutical Statistics, 2004, v. 14, n. 2, p. 359, doi. 10.1081/BIP-120037186

By:

Tsong, Yi;
Zhang, Juan (Joanne);
Wang, Sue Jane

Publication type:

Article

ISSUES RELATED TO SUBGROUP ANALYSIS IN CLINICAL TRIALS.

Published in:

Journal of Biopharmaceutical Statistics, 2002, v. 12, n. 3, p. 347, doi. 10.1081/BIP-120014565

By:

Cui, Lu;
James Hung, H. M.;
Wang, Sue Jane;
Tsong, Yi

Publication type:

Article

A simple and efficient algorithm for genome-wide homozygosity analysis in disease.

Published in:

Molecular Systems Biology, 2009, v. 5, n. 1, p. 304, doi. 10.1038/msb.2009.53

By:

Liu, Wei;
Ding, Jinhui;
Gibbs, Jesse Raphael;
Wang, Sue Jane;
Hardy, John;
Singleton, Andrew

Publication type:

Article

Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshop.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2014, v. 41, n. 6, p. 545, doi. 10.1007/s10928-014-9390-0

By:

Romero, Klaus;
Sinha, Vikram;
Allerheiligen, Sandra;
Danhof, Meindert;
Pinheiro, Jose;
Kruhlak, Naomi;
Wang, Yaning;
Wang, Sue-Jane;
Sauer, John-Michael;
Marier, J.;
Corrigan, Brian;
Rogers, James;
Lambers Heerspink, H.;
Gumbo, Tawanda;
Vis, Peter;
Watkins, Paul;
Morrison, Tina;
Gillespie, William;
Gordon, Mark;
Stephenson, Diane

Publication type:

Article

A closed procedure based on follmann's test for the analysis of multiple endpoints.

Published in:

Communications in Statistics: Theory & Methods, 1998, v. 27, n. 10, p. 2461, doi. 10.1080/03610929808832237

By:

Wang, Sue-Jane

Publication type:

Article

Evaluation of external RNA controls for the assessment of microarray performance.

Published in:

Nature Biotechnology, 2006, v. 24, p. 1132, doi. 10.1038/nbt1237

By:

Weida Tong;
Lucas, Anne Bergstrom;
Shippy, Richard;
Xiaohui Fan;
Hong Fang;
Huixiao Hong;
Orr, Michael S.;
Tzu-Ming Chu;
Xu Guo;
Collins, Patrick J.;
Sun, Yongming Andrew;
Sue-Jane Wang;
Wenjun Bao;
Wolfinger, Russell D.;
Shchegrova, Svetlana;
Lei Guo;
Warrington, Janet A.;
Leming Shi

Publication type:

Article

Evaluation of external RNA controls for the assessment of microarray performance.

Published in:

Nature Biotechnology, 2006, v. 24, n. 9, p. 1132, doi. 10.1038/nbt1237

By:

Weida Tong;
Lucas, Anne Bergstrom;
Shippy, Richard;
Xiaohui Fan;
Hong Fang;
Huixiao Hong;
Orr, Michael S.;
Tzu-Ming Chu;
Xu Guo;
Collins, Patrick J.;
Sun, Yongming Andrew;
Sue-Jane Wang;
Wenjun Bao;
Wolfinger, Russell D.;
Shchegrova, Svetlana;
Lei Guo;
Warrington, Janet A.;
Leming Shi

Publication type:

Article

Quantitative Brain Amyloid PET.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 5, p. 670, doi. 10.2967/jnumed.123.265766

By:

Jagust, William J.;
Mattay, Venkata S.;
Krainak, Daniel M.;
Sue-Jane Wang;
Weidner, Lora D.;
Hofling, A. Alex;
Hayoung Koo;
Hsieh, Pamela;
Kuo, Phillip H.;
Farrar, Gill;
Marzella, Libero

Publication type:

Article

Prostate Cancer Theranostics: Concurrent Approvals by the Food and Drug Administration of the First Diagnostic Imaging Drug Indicated to Select Patients for a Paired Radioligand Therapeutic Drug.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 11, p. 1642, doi. 10.2967/jnumed.122.264299

By:

Hofling, A. Alex;
Fotenos, Anthony F.;
Gang Niu;
Fallah, Jaleh;
Agrawal, Sundeep;
Sue-Jane Wang;
Marzella, Libero

Publication type:

Article

Prostate Cancer Theranostics: Concurrent Approvals by the Food and Drug Administration of the First Diagnostic Imaging Drug Indicated to Select Patients for a Paired Radioligand Therapeutic Drug.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264299

By:

Hofling, A. Alex;
Fotenos, Anthony F.;
Gang Niu;
Fallah, Jaleh;
Agrawal, Sundeep;
Sue-Jane Wang;
Marzella, Libero

Publication type:

Article

Prostate Cancer Theranostics: Concurrent Approvals by the Food and Drug Administration of the First Diagnostic Imaging Drug Indicated to Select Patients for a Paired Radioligand Therapeutic Drug.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264299

By:

Hofling, A. Alex;
Fotenos, Anthony F.;
Gang Niu;
Fallah, Jaleh;
Agrawal, Sundeep;
Wang, Sue-Jane;
Marzella, Libero

Publication type:

Article

Prostate Cancer Theranostics: Concurrent Approvals by the Food and Drug Administration of the First Diagnostic Imaging Drug Indicated to Select Patients for a Paired Radioligand Therapeutic Drug.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.122.264299

By:

Hofling, A. Alex;
Fotenos, Anthony F.;
Gang Niu;
Fallah, Jaleh;
Agrawal, Sundeep;
Sue-Jane Wang;
Marzella, Libero

Publication type:

Article

The impact of misclassification errors on the performance of biomarkers based on next-generation sequencing, a simulation study.

Published in:

Journal of Biopharmaceutical Statistics, 2024, v. 34, n. 5, p. 700, doi. 10.1080/10543406.2023.2269251

By:

Wang, Dong;
Wang, Sue-Jane;
Lababidi, Samir

Publication type:

Article

The i3+3 design for phase I clinical trials.

Published in:

Journal of Biopharmaceutical Statistics, 2020, v. 30, n. 2, p. 294, doi. 10.1080/10543406.2019.1636811

By:

Liu, Meizi;
Wang, Sue-Jane;
Ji, Yuan

Publication type:

Article

Commentary on "Applying CHW method to 2-in-1 design: gain or lose".

Published in:

Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 4, p. 722, doi. 10.1080/10543406.2019.1634088

By:

Cui, Lu;
Hung, H.M. James;
Wang, Sue Jane

Publication type:

Article

Rejoinder to Dr. Cyrus R. Mehta.

Published in:

Journal of Biopharmaceutical Statistics, 2016, v. 26, n. 2, p. 405, doi. 10.1080/10543406.2015.1099542

By:

Hung, H.M. James;
Wang, Sue-Jane;
Yang, Peiling

Publication type:

Article

Statistical challenges in a regulatory review of cardiovascular and CNS clinical trials.

Published in:

Journal of Biopharmaceutical Statistics, 2016, v. 26, n. 1, p. 37, doi. 10.1080/10543406.2015.1092025

By:

Hung, H. M. James;
Wang, Sue-Jane;
Yang, Peiling;
Jin, Kun;
Lawrence, John;
Kordzakhia, George;
Massie, Tristan

Publication type:

Article

Some Challenges With Statistical Inference in Adaptive Designs.

Published in:

Journal of Biopharmaceutical Statistics, 2014, v. 24, n. 5, p. 1059, doi. 10.1080/10543406.2014.925911

By:

Hung, H. M. James;
Wang, Sue-Jane;
Yang, Peiling

Publication type:

Article

Guest Editors’ Note: Special Issue on Subgroup Analysis in Clinical Trials.

Published in:

Journal of Biopharmaceutical Statistics, 2014, v. 24, n. 1, p. 1, doi. 10.1080/10543406.2014.858958

By:

Wang, Sue-Jane;
Dmitrienko, Alex

Publication type:

Article

Standardization for Subgroup Analysis in Randomized Controlled Trials.

Published in:

Journal of Biopharmaceutical Statistics, 2014, v. 24, n. 1, p. 154, doi. 10.1080/10543406.2013.856023

By:

Varadhan, Ravi;
Wang, Sue-Jane

Publication type:

Article

A Regulatory Perspective on Essential Considerations in Design and Analysis of Subgroups When Correctly Classified.

Published in:

Journal of Biopharmaceutical Statistics, 2014, v. 24, n. 1, p. 19, doi. 10.1080/10543406.2013.856022

By:

Wang, Sue-Jane;
Hung, H. M.James

Publication type:

Article

Ethnic Sensitive or Molecular Sensitive Beyond All Regions Being Equal in Multiregional Clinical Trials.

Published in:

Journal of Biopharmaceutical Statistics, 2012, v. 22, n. 5, p. 879, doi. 10.1080/10543406.2012.701576

By:

Wang, Sue-Jane;
James Hung, H.M.

Publication type:

Article

Sample Size Adaptation in Fixed-Dose Combination Drug Trial.

Published in:

Journal of Biopharmaceutical Statistics, 2012, v. 22, n. 4, p. 679, doi. 10.1080/10543406.2012.676533

By:

James Hung, H.M.;
Wang, Sue-Jane

Publication type:

Article

Regulatory Perspectives on Multiplicity in Adaptive Design Clinical Trials throughout a Drug Development Program.

Published in:

Journal of Biopharmaceutical Statistics, 2011, v. 21, n. 4, p. 846, doi. 10.1080/10543406.2011.552878

By:

Wang, Sue-Jane;
James Hung, H.M.;
O'Neill, Robert

Publication type:

Article

Perspectives on the Use of Adaptive Designs in Clinical Trials. Part II. Panel Discussion.

Published in:

Journal of Biopharmaceutical Statistics, 2010, v. 20, n. 6, p. 1098, doi. 10.1080/10543406.2010.514447

By:

Benda, Norbert;
Brannath, Werner;
Bretz, Frank;
Burger, Hans-Ulrich;
Friede, Tim;
Maurer, Willi;
Wang, Sue-Jane

Publication type:

Article

Perspectives on the Use of Adaptive Designs in Clinical Trials. Part I. Statistical Considerations and Issues.

Published in:

Journal of Biopharmaceutical Statistics, 2010, v. 20, n. 6, p. 1090, doi. 10.1080/10543406.2010.514446

By:

Wang, Sue-Jane

Publication type:

Article

Editorial: Adaptive Designs: Appealing in Development of Therapeutics, and Where do Controversies Lie?

Published in:

Journal of Biopharmaceutical Statistics, 2010, v. 20, n. 6, p. 1083, doi. 10.1080/10543406.2010.514461

By:

Wang, Sue-Jane

Publication type:

Article

Some Controversial Multiple Testing Problems in Regulatory Applications.

Published in:

Journal of Biopharmaceutical Statistics, 2009, v. 19, n. 1, p. 1, doi. 10.1080/10543400802541693

By:

Hung, H. M. James;
Wang, Sue-Jane

Publication type:

Article

Statistical Considerations for Testing Multiple Endpoints in Group Sequential or Adaptive Clinical Trials.

Published in:

Journal of Biopharmaceutical Statistics, 2007, v. 17, n. 6, p. 1201, doi. 10.1080/10543400701645405

By:

Hung, H. M. James;
Wang, Sue-Jane;
O'Neill, Robert

Publication type:

Article

Discussion of the "White Paper of the PhRMA Working Group on Adaptive Dose-Ranging Designs".

Published in:

Journal of Biopharmaceutical Statistics, 2007, v. 17, n. 6, p. 1015, doi. 10.1080/10543400701643897

By:

Wang, Sue-Jane

Publication type:

Article

A targeted simulation‐extrapolation method for evaluating biomarkers based on new technologies in precision medicine.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 3, p. 584, doi. 10.1002/pst.2187

By:

Wang, Dong;
Wang, Sue‐Jane;
Xu, Joshua;
Lababidi, Samir

Publication type:

Article

An evidential approach to non-inferiority clinical trials.

Published in:

Pharmaceutical Statistics, 2011, v. 10, n. 5, p. 440, doi. 10.1002/pst.513

By:

Wang, Sue-Jane;
Blume, Jeffrey D.

Publication type:

Article

Multi-regional clinical trials - What are the challenges?

Published in:

Pharmaceutical Statistics, 2010, v. 9, n. 3, p. 171, doi. 10.1002/pst.457

By:

Wang, Sue-Jane

Publication type:

Article

Trial design issues and treatment effect modeling in multi-regional schizophrenia trials.

Published in:

Pharmaceutical Statistics, 2010, v. 9, n. 3, p. 217, doi. 10.1002/pst.439

By:

Chen, Yeh-Fong;
Wang, Sue-Jane;
Khin, Ni A.;
Hung, H. M. James;
Laughren, Thomas P.

Publication type:

Article

Consideration of regional difference in design and analysis of multi-regional trials.

Published in:

Pharmaceutical Statistics, 2010, v. 9, n. 3, p. 173, doi. 10.1002/pst.440

By:

Hung, H. M. James;
Wang, Sue-Jane;
O'Neill, Robert T.

Publication type:

Article

Biomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th anniversary of PSI.

Published in:

Pharmaceutical Statistics, 2007, v. 6, n. 4, p. 283, doi. 10.1002/pst.316

By:

Wang, Sue-Jane

Publication type:

Article

Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset.

Published in:

Pharmaceutical Statistics, 2007, v. 6, n. 3, p. 227, doi. 10.1002/pst.300

By:

Wang, Sue-Jane;
O'Neill, Robert T.;
Hung, H. M. James

Publication type:

Article

Editorial.

Published in:

Pharmaceutical Statistics, 2006, v. 5, n. 3, p. 157, doi. 10.1002/pst.236

By:

Julious, Steven A.;
Wang, Sue-Jane

Publication type:

Article

Methodological issues with adaptation of clinical trial design.

Published in:

Pharmaceutical Statistics, 2006, v. 5, n. 2, p. 99, doi. 10.1002/pst.219

By:

James Hung, H. M.;
Wang, Sue-Jane;
O'Neill, Robert T.

Publication type:

Article

Editorial.

Published in:

Pharmaceutical Statistics, 2006, v. 5, n. 2, p. 81, doi. 10.1002/pst.225

By:

Julious, Steven A.;
Wang, Sue-Jane

Publication type:

Article

Adapting the sample size planning of a phase III trial based on phase II data.

Published in:

Pharmaceutical Statistics, 2006, v. 5, n. 2, p. 85, doi. 10.1002/pst.217

By:

Wang, Sue-Jane;
Hung, H. M. James;
O'Neill, Robert T.

Publication type:

Article

Lots Achieved, Lots More To Do.

Published in:

Pharmaceutical Statistics, 2006, v. 5, n. 1, p. 1, doi. 10.1002/pst.201

By:

Furlong, Larry;
Julious, Steven A.;
Wang, Sue-Jane

Publication type:

Article